Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 5
2007 4
2008 5
2009 7
2010 6
2011 11
2012 18
2013 18
2014 16
2015 12
2016 22
2017 14
2018 12
2019 20
2020 43
2021 45
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

237 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis.
Devos D, Moreau C, Kyheng M, Garçon G, Rolland AS, Blasco H, Gelé P, Timothée Lenglet T, Veyrat-Durebex C, Corcia P, Dutheil M, Bede P, Jeromin A, Oeckl P, Otto M, Meininger V, Danel-Brunaud V, Devedjian JC, Duce JA, Pradat PF. Devos D, et al. Among authors: moreau c. Sci Rep. 2019 Feb 27;9(1):2918. doi: 10.1038/s41598-019-39739-5. Sci Rep. 2019. PMID: 30814647 Free PMC article. Clinical Trial.
Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Devos D, Cabantchik ZI, Moreau C, Danel V, Mahoney-Sanchez L, Bouchaoui H, Gouel F, Rolland AS, Duce JA, Devedjian JC; FAIRPARK-II and FAIRALS-II studygroups. Devos D, et al. Among authors: moreau c. J Neural Transm (Vienna). 2020 Feb;127(2):189-203. doi: 10.1007/s00702-019-02138-1. Epub 2020 Jan 7. J Neural Transm (Vienna). 2020. PMID: 31912279 Free article. Review.
Gender and Health in Very Young Adolescents.
Moreau C, Blum R, Mmari K, Hunersen K, Mafuta E, Lulebi A, Wilopo S, Stones W, Shervington D, Michielsen K, Lou C, Borges AL, Maddaleno M. Moreau C, et al. J Adolesc Health. 2021 Jul;69(1S):S3-S4. doi: 10.1016/j.jadohealth.2021.04.012. J Adolesc Health. 2021. PMID: 34217456 Free article. No abstract available.
Clinical syndromes: Parkinsonian gait.
Ebersbach G, Moreau C, Gandor F, Defebvre L, Devos D. Ebersbach G, et al. Among authors: moreau c. Mov Disord. 2013 Sep 15;28(11):1552-9. doi: 10.1002/mds.25675. Mov Disord. 2013. PMID: 24132843 Review.
Iron as a therapeutic target for Parkinson's disease.
Moreau C, Duce JA, Rascol O, Devedjian JC, Berg D, Dexter D, Cabantchik ZI, Bush AI, Devos D; FAIRPARK-II study group. Moreau C, et al. Mov Disord. 2018 Apr;33(4):568-574. doi: 10.1002/mds.27275. Epub 2018 Jan 30. Mov Disord. 2018. PMID: 29380903 Review. No abstract available.
[SARS-CoV-2 and neurological disorders: the revelance of biomarkers?].
Bigot-Corbel E, Lanore A, Raulet C, Delorme C, Azulay JP, Lehmann S, Beaudeux JL, Beauvieux MC, Sapin V, Peoc'h K, Rucheton B; Membres du groupe de travail « SFBC Marqueurs biochimiques COVID-19 ». Bigot-Corbel E, et al. Ann Biol Clin (Paris). 2021 Feb 1;79(1):7-16. doi: 10.1684/abc.2021.1622. Ann Biol Clin (Paris). 2021. PMID: 33570039 Review. French.
237 results